Orally Active Inhibitors of Human Leukocyte Elastase
J ournal of Medicinal Chemistry, 1997, Vol. 40, No. 20 3181
(7) Banda, M. J .; Rice, A. G.; Griffin, G. L.; Senior, R. M. R1-
Proteinase Inhibitor Is a Neutrophil Chemoattractant after
Proteolytic Inactivation by Macrophage Elastase. J . Biol. Chem.
1988, 263, 4481-4484.
(8) Sandhaus, R. A. Elastase May Play A Central Role in Neutrophil
Migration Through Connective Tissue. In Pulmonary Emphy-
sema and Proteolysis: 1986; Taylor, J . C., Mittman, C., Eds.;
Academic Press Inc.: New York, 1987; pp 227-234.
(9) Demling, R. H. The Modern Version of the Adult Respiratory
Distress Syndrome. Annu. Rev. Med. 1995, 46, 193-202.
(10) Donnelly, S. C.; MacGregor, I.; Zamani, A.; Gordon, M. W. G.;
Robertson, C. E.; Steedman, D. J .; Little, K.; Haslett, C. Plasma
Elastase Levels and the Development of the Adult Respiratory
Distress Syndrome. Am. J . Respir. Crit. Care Med. 1995, 151,
1428-1433.
(11) For a recent review on elastase inhibitors see: Edwards, P. D.;
Bernstein, P. R. Synthetic Inhibitors of Elastase. Med. Res. Rev.
1994, 14, 127-194.
K.; Chandler, G. O.; Knight, W. B.; Matcock, A. L.; Ashe, B. M.;
Weston, H.; Gale, P.; Mumford, R. A.; Anderson, O. F.; Williams,
H. R.; Nolan, T. E.; Frankenfield, D. L.; Underwood, D.; Vyas,
K. P.; Kari, P. H.; Dahlgren, M. E.; Mao, J .; Fletcher, D. S.;
Dellea, P. S.; Hand, K. M.; Osinga, D. G.; Peterson, L. B.;
Williams, D. T.; Metzger, J . M.; Bonney, R. J .; Humes, J . L.;
Pacholok, S. P.; Hanlon, W. A.; Opas, E.; Stolk, J .; Davies, P.
Chemical, biochemical, pharmacokinetic, and biological proper-
ties of L-680,833: A potent, orally active monocyclic â-lactam
inhibitor of human polymorphonuclear leukocyte elastase Proc.
Natl. Acad. Sci. U.S.A. 1993, 90, 8727-8731. (d) Angelastro, M.
R.; Baugh, L. E.; Bey, P.; Burkhart, J . P.; Chen, T. M.; Durham,
S. L.; Hare, C. M.; Huber, E. W.; J anusz, M. J .; Koehl, J . R.;
Marquart, A. L.; Mehdi, S.; Peet. N. P. Inhibition of Human
Neutrophil Elastase with Peptidyl Electrophilic Ketones. 2.
Orally Active Pg-Val-Pro-Val Pentafluoroethyl Ketones. J . Med.
Chem. 1994, 37, 4538-4554. (e) Orally Active b-Lactam Inhibi-
tors of Human Leukocyte Elastase. 3. Stereospecific Synthesis
and Structure Activity Relationships for 3,3-Dialkylazetidin-2-
ones. Finke, P. E.; Shah, S. K.; Fletcher, D. S.; Ashe, B. M.;
Brause, K. A.; Chandler, G. O.; Dellea, P. S.; Hnad, K. M.;
Maycock, A. L.; Osinga, D. G.; Underwood, D. J .; Weston, H.;
Davies, P.; Doherty, J . B. J . Med. Chem. 1995, 38, 2449-2462.
(15) Edwards, P. D.; Schwartz, J . A.; Stein, M. M.; Trainor, D. A.;
Wildonger, R. A. U.S. Patent 5,194,588, 1993.
(16) Fearon, K.; Spaltenstein, A.; Hopkins, P. B.; Gelb, M. H. Fluoro
Ketone Containing Peptides as Inhibitors of Human Renin. J .
Med. Chem. 1987, 30, 1617-1622.
(17) Trainor, D. A.; Stein, M. M. U.S. Patent 4,880,780, 1989.
(18) Edwards, P. D.; Wolanin, D. J .; Andisik, D. W.; Davis, M. W.
Peptidyl R-Ketoheterocyclic Inhibitors of Human Leukocyte
Elastase. 2. Effect of Varying the Heterocyclic Ring on in Vitro
Potency. J . Med. Chem. 1995, 38, 76-85.
(19) Bernstein, P. R.; Kosmider, B. J .; Vacek, E. P.; Veale, C. A.;
Gomes, B. C. Examination of Peptidic R′,â′-Diamino-R-R-Difluo-
roketones as Inhibitors of Human Leukocyte Elastase. Bioorg.
Med. Chem. Lett. 1994, 4, 2175-2178.
(20) Fletcher, D. S.; Osinga, D. G.; Hand, K. M.; Dellea, P. S.; Ashe,
B. M.; Mumford, R. A.; Davies, P.; Hagmann, W. K.; Finke, P.
E.; Doherty, J . B.; Bonney, R. J . A Comparison of alpha-1-
Proteinase Inhibitor, Methoxysuccincyl-Ala-Ala-Pro-Val-Chloro-
Methylketone, and Specific Beta-Lactam Inhibitors in Acute
Model of Human PMN Elastase-Induced Lung Hemorrhage in
the Hamster. Am. Rev. Respir. Dis. 1990, 141, 672-677.
(21) Edwards, P. D.; Wolanin, D. J .; Andisik, D. W.; Davis, M. W.
Peptidyl R-Ketoheterocyclic Inhibitors of Human Neutrophil
Elastase. 2. Effect of Varying the Heterocyclic Ring on in vitro
Potency. J . Med. Chem. 1995, 38, 76-85.
(22) Edwards, P. D.; Zottola, M. A.; Davis, M.; Williams, J . C.; Tuthill,
P. A. Peptidyl R-Ketoheterocyclic Inhibitors of Human Neutro-
phil Elastase. 3. In Vitro and in Vivo Potency of a Series of
Peptidyl R-Ketobenzoxazoles. J . Med. Chem. 1995, 38, 3972-
3982.
(23) The rate of chemical degradation, extrapolated to 25 °C, indicates
a half-life for 1h of 0.7 days at pH 10, 5.5 days at pH 8, 34 days
at pH 6, and 120 days at pH 4. Conversely compound 1c was
found to completely decompose at pH 10 in less than 1 h.
(24) Edwards, P. D. A Method for the Stereoselective Synthesis of
Peptidyl Trifluoromethyl Ketones. Tetrahedron Lett. 1992, 33,
4279-4282.
(25) Williams, J . C.; Falcone, R. C.; Knee, C.; Stein, R. L.; Strimple,
A. M.; Reaves, B.; Giles, R. E.; Krell, R. D. Biologic Character-
ization of ICI-200,880 and ICI-200,355, Novel Inhibitors of
Human Neutrophil Elastase. Am. Rev. Respir. Dis. 1991, 144,
875-883.
(26) Physical property characterization consisted of evaluation of
aqueous solubility, crystallinity, and hygroscopicity.
(27) Bernstein, P. B.; Veale, C. A.; Davies, E. P Proline Derivatives
as Inhibitors of Human Leukocyte Elastase International Patent
Application WO 96/23812, published August 8, 1996.
(12) (a) Brown, F. J .; Andisik, D. W.; Bernstein, P. B.; Bryant, C. B.;
Ceccarelli, C.; Damewood, J . R., J r.; Edwards, P. D.; Earley, R.
A.; Feeney, S.; Green, R. C.; Gomes, B. C.; Kosmider, B. J .; Krell,
R. D.; Shaw, A.; Steelman, G. B.; Thomas, R. M.; Vacek, E. P.;
Veale, C. A.; Tuthill, P. A.; Warner, P.; Williams, J . C.; Wolanin,
D. J .; Woolson, S. A. The Design of Orally Active, Nonpeptidic
Inhibitors of Human Leukocyte Elastase. J . Med. Chem. 1994,
37, 1259-1261. (b) Warner, P.; Green, R. C.; Gomes, B. C.;
Williams, J . C. Nonpeptidic Inhibitors of Human Leukocyte
Elastase. 1. The Design and Synthesis of Pyridone-Containing
Inhibitors. J . Med. Chem. 1994, 37, 3090-3099. (c) Damewood,
J . R. J r.; Edwards, P. D., Feeney, S.; Gomes, B. C.; Steelman,
G. B.; Tuthill, P. A.; Williams, J . C.; Warner, P.; Woolson, S. A.;
Wolanin, D. J .; Veale, C. A. Nonpeptidic Inhibitors of Human
Leukocyte Elastase. 2. Design, Synthesis, and In Vitro Activity
of a Series of 3-Amino-6-arylpyridin-2-one-trifluoromethylke-
tones. J . Med. Chem. 1994, 37, 3303-3312. (d) Bernstein, P. B.;
Andisik, D.; Bradley, P. K.; Bryant, C. B.; Ceccarelli, C.;
Damewood, J . R., J r.; Earley, R.; Feeney, S.; Gomes, B. C.;
Kosmider, B. J .; Steelman. G. B.; Thomas, R. M.; Vacek, E. P.;
Veale, C. A.; Williams, J . C.; Wolanin, D. J .; Woolson, S. A.
Nonpeptidic Inhibitors of Human Leukocyte Elastase. 3. Design,
Synthesis, X-Ray Crystallographic Analysis, and Structure-
Activity Relationships for a Series of Orally Active 3-Amino-6-
phenylpyridin-2-ones. J . Med. Chem. 1994, 37, 3313-3326. (e)
Veale, C. A.; Damewood, J . R., J r.; Steelman, G. B.; Bryant, C.
B.; Gomes, B. C.; Williams, J . C. Nonpeptidic Inhibitors of
Human Leukocyte Elastase. 4. Design, Synthesis, and Structure-
Activity Relationships for a Series of â-Carbolinones. J . Med.
Chem. 1995, 38, 86-97. (f) Veale, C. A.; Bernstein, P. R.; Bryant,
C. B.; Ceccarelli, C.; Damewood, J . R., J r.; Earley, R.; Feeney,
S. W.; Gomes, B. C.; Kosmider, B. J .; Steelman, G. B.; Thomas,
R. M.; Vacek, E. P.; Williams, J . C.; Wolanin, D. J .; Woolson, S.
A. Nonpeptidic Inhibitors of Human Leukocyte Elastase. 5.
Design, Synthesis, and X-ray Crystallography of a Series of
Orally Active 5-Aminopyrimidin-6-one-Containing Trifluoro-
methylketones. J . Med. Chem. 1995, 38, 98-108.
(13) Edwards, P. D.; Andisik, D. W.; Bryant, C. A.; Ewing, B.; Gomes,
B. C.; Lewis, J . L.; Rakiewicz, D.; Steelman, G. B.; Strimpler,
A.; Trainor, D. A.; Tuthill, P. A.; Mauger, R. C.; Veale, C. A.;
Wildonger, R. A.; Williams, J . C.; Wolanin, D. J .; Zottola, M.
The Discovery and Biological Activity of Orally Active Peptidyl
Trifluoromethyl Ketone Inhibitors of Human Neutrophil Elastase.
J . Med. Chem. 1997, 40, 1876-1885.
(14) For work on elastase carried out by other groups, see: (a) Peet,
N. P.; Burkhart, J . P.; Angelastro, M. R.; Giroux, E. L.; Mehdi,
S.; Bey, P; Kolb, M.; Neises, B.; Schirlin, D. Synthesis of Peptidyl
Fluoromethyl Ketones and Peptidyl R Keto Esters as Inhibitors
of Porcine Pancreatic Elastase, Human Neutrophil Elastase, and
Rat and Human Neutrophil Cathepsin G. J . Med. Chem. 1990,
33, 394-407. (b) Angelastro, M. R.; Bey, P.; Mehdi, S.; J anusz,
M. J .; Peet, N. P. J anus Compounds: Dual Inhibitors of
Proteinases. Bioorg. Med. Chem. Lett. 1993, 3, 525-530. (c)
Doherty, J . B.; Shah, S. K.; Finke, P. E.; Dorn, C. P.; Hagmann,
W. K.; Hale, J . J .; Kissinger, A. L.; Thompson, K. R.; Brause,
J M970250Z